Tagged with IFPMA

The WHO Pandemic Treaty & Three Key Lessons from the COVID-19 Response
Flu Vaccination More Important Than Ever to Ensure Global Healthcare Systems Protect Most Vulnerable
Enough COVID Vaccines for World Population Says IFPMA: Calls for End to Vaccine Stockpiling & IP Waiver Requests
Industry Warns of Vaccine Manufacturing Bottlenecks; Specific Data Still Lacking
IP PACT: A Journey, Not a Destination
Innovative Pharma Doubles Down on IP with New Pact
The COVID-19 Vaccine Rush: Nationalism, Access & IP Issues
IFPMA’s Thomas Cueni on why “#TeamVaccines is all of us”
Global Pharma Execs Hail ‘Unprecedented’ Speed & Collaboration of COVID-19 Response
New Billion Dollar Pharma Action Fund to Counter ‘Slow Tsunami’ of Antimicrobial Resistance
What Can a Plasma ‘Alliance’ do for COVID-19?
Speeding up the Search for Safe & Effective COVID-19 Therapies & Vaccines
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here